SPOTLIGHT: WHO: New sleep meds little better than old
A WHO analysis finds that new-generation sleep meds like Ambien and Lunesta have side effects that are "nearly as problematic" as older drugs such as Halcion, which was banned in some countries. Report
Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product
Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.